These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2767024)

  • 21. The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson's disease: a discriminant analytic approach.
    Leentjens AF; Marinus J; Van Hilten JJ; Lousberg R; Verhey FR
    J Neuropsychiatry Clin Neurosci; 2003; 15(1):74-7. PubMed ID: 12556575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coping with disease-related stressors in Parkinson's disease.
    Frazier LD
    Gerontologist; 2000 Feb; 40(1):53-63. PubMed ID: 10750313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.
    Montel S; Bonnet AM; Bungener C
    J Geriatr Psychiatry Neurol; 2009 Jun; 22(2):95-102. PubMed ID: 19150974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression in Parkinson's disease: reconciling physiological and psychological perspectives.
    Taylor AE; Saint-Cyr JA
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):92-8. PubMed ID: 2136067
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of fatigue on health-related quality of life in patients with Parkinson's disease.
    Herlofson K; Larsen JP
    Acta Neurol Scand; 2003 Jan; 107(1):1-6. PubMed ID: 12542506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apathy in Parkinson's disease.
    Pluck GC; Brown RG
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):636-42. PubMed ID: 12438462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Causal "cancer personality" attribution--an expression of maladaptive coping with illness?].
    Faller H; Lang H; Schilling S
    Z Klin Psychol Psychiatr Psychother; 1996; 44(1):104-16. PubMed ID: 8686364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of quality of life in people with Parkinson's disease: evidence for both domain specific and general relationships.
    Simpson J; Lekwuwa G; Crawford T
    Disabil Rehabil; 2014; 36(23):1964-70. PubMed ID: 24499208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hedonic tone and its mood and cognitive correlates in Parkinson's disease.
    Spalletta G; Fagioli S; Meco G; Pierantozzi M; Stefani A; Pisani V; Caltagirone C; Pontieri FE; Assogna F
    Depress Anxiety; 2013 Jan; 30(1):85-91. PubMed ID: 23300113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosocial problems of Parkinson patients: approaches to assessment and treatment.
    Ellgring H; Seiler S; Nagel U; Perleth B; Gasser T; Oertel WH
    Adv Neurol; 1990; 53():349-53. PubMed ID: 2239476
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease.
    Huber SJ; Paulson GW; Shuttleworth EC
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):855-8. PubMed ID: 3404193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Functional somatic syndromes, one or many?" An answer by cluster analysis.
    Lacourt T; Houtveen J; van Doornen L
    J Psychosom Res; 2013 Jan; 74(1):6-11. PubMed ID: 23272982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuropsychiatric problems in patients with Parkinson's disease].
    Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What contributes to quality of life in patients with Parkinson's disease?
    Schrag A; Jahanshahi M; Quinn N
    J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):308-12. PubMed ID: 10945804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric symptoms in Serbian patients with Parkinson's disease.
    Petrovic M; Stefanova E; Ziropadja L; Stojkovic T; Kostic VS
    J Neurol Sci; 2016 Aug; 367():342-6. PubMed ID: 27423616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological impairments associated with severity of Parkinson's disease.
    Huber SJ; Freidenberg DL; Shuttleworth EC; Paulson GW; Christy JA
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):154-8. PubMed ID: 2521056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Markers of Anxiety Subtypes in Parkinson Disease.
    Broen MPG; Leentjens AFG; Hinkle JT; Moonen AJH; Kuijf ML; Fischer NM; Perepezko K; Bakker A; Pontone GM
    J Geriatr Psychiatry Neurol; 2018 Mar; 31(2):55-62. PubMed ID: 29528763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairments and depression in Parkinson's disease: a follow up study.
    Starkstein SE; Bolduc PL; Mayberg HS; Preziosi TJ; Robinson RG
    J Neurol Neurosurg Psychiatry; 1990 Jul; 53(7):597-602. PubMed ID: 2391525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent class analysis differentiation of adjustment disorder and demoralization, more severe depressive and anxiety disorders, and somatic symptoms in patients with cancer.
    Bobevski I; Kissane DW; Vehling S; McKenzie DP; Glaesmer H; Mehnert A
    Psychooncology; 2018 Nov; 27(11):2623-2630. PubMed ID: 29761579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affective disturbances in Alzheimer's disease.
    Bungener C; Jouvent R; Derouesné C
    J Am Geriatr Soc; 1996 Sep; 44(9):1066-71. PubMed ID: 8790232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.